Evidence map›Paper›PMID 28440970›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2017

Factors Associated with Cigarette Smoking in Central Parts of Iran

Mujtaba Shuja, Nizal Sarrafzadegan, Hamid Reza Roohafza, Masoumeh Sadeghi, Mahin Ghafari, Mahdi Mohammadian, Abdollah Mohammadian Hafshejani

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mujtaba ShujaResearcher, Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran. Email: amohamadii1361@gmail.com.
Nizal Sarrafzadegan
Hamid Reza Roohafza
Masoumeh Sadeghi
Mahin Ghafari
Mahdi Mohammadian
Abdollah Mohammadian Hafshejani

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study aims to assess factors associated with cigarette smoking in central parts of Iran. Materials and methods: We used the data of the post intervention phase of Isfahan Healthy Heart Program (IHHP) that was conducted in 2007. Logistic regression was used for calculating crude and adjusted Odds Ratios (OR). The group with the least prevalence of smoking was considered as the Reference Group (RG) and the OR for other parts of the variable was calculated based on the RG and reported with a confidence interval of 95%. Findings: Generally, 9513 individuals participated in the study, of which 13.5% were smokers (26.2% of men and 0.8% of women). The OR for cigarette smoking in men compared with women in (RG) was 13.89 (95% Confidence Interval (CI) 7.44–24.82). Among rural areas, compared with urban areas in (RG), the OR was 0.98 (95% CI 0.82–1.15); and among elementary education level compared to illiterate individuals the OR was 4.37 (95% CI 1.68–10.76). The OR in individuals in the age group 35–44, compared with the age group of 65 and older in (RG) was 2.49 (95% CI 1.81–3.45). The place most used for cigarette smoking was streets (72.1%); and the main reason for starting or continuing cigarette smoking, according to smokers’ opinions, was pleasure and fun. Conclusion: The highest number of smokers was in 35-44 years men, in rural areas, with elementary education level; so, they are the ones who need more attention through implementation of educational programs for awareness, improved attitudes and practices, and smoking cessation programs.

Indexed as

CigaretteIranlogistic regressionodds ratio

Identifiers

PMID28440970
PMCPMC5464479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.